Has the Japanese Packaged Foods and Meats Industry valuation changed over the past few years?

Investors are relatively neutral on the industry at the moment, indicating that they anticipate long term growth rates to remain steady. The industry is trading close to its 3-year average PE ratio of 17.6x.

How does Japanese Packaged Foods and Meats compare with similar industries?

There is insufficient data on the sub-industries of this industry.

Japanese (NIKKEI) Packaged Foods and Meats Industry Analysis

Date	Market Cap	Revenue	Earnings	PE
Sat, 21 May 2022	JP¥13.1t	JP¥19.4t	JP¥791.7b	14.8x
Mon, 18 Apr 2022	JP¥13.6t	JP¥19.4t	JP¥767.1b	14x
Wed, 16 Mar 2022	JP¥13.8t	JP¥19.3t	JP¥763.8b	14.7x
Fri, 11 Feb 2022	JP¥14.0t	JP¥19.4t	JP¥760.3b	15.5x
Sun, 09 Jan 2022	JP¥14.2t	JP¥19.2t	JP¥756.1b	15.5x
Tue, 07 Dec 2021	JP¥13.8t	JP¥19.2t	JP¥755.4b	14.4x
Thu, 04 Nov 2021	JP¥14.8t	JP¥19.2t	JP¥708.5b	16.4x
Sat, 02 Oct 2021	JP¥14.6t	JP¥19.2t	JP¥708.8b	16.7x
Mon, 30 Aug 2021	JP¥14.5t	JP¥19.5t	JP¥716.9b	16.8x
Tue, 06 Jul 2021	JP¥13.7t	JP¥19.5t	JP¥716.6b	16.5x
Fri, 09 Apr 2021	JP¥13.7t	JP¥19.4t	JP¥662.5b	17.4x
Thu, 31 Dec 2020	JP¥13.6t	JP¥19.6t	JP¥626.3b	18.3x
Sun, 04 Oct 2020	JP¥14.0t	JP¥19.7t	JP¥611.8b	19.2x
Wed, 08 Jul 2020	JP¥13.3t	JP¥19.8t	JP¥574.4b	19.7x
Tue, 31 Mar 2020	JP¥12.9t	JP¥20.1t	JP¥582.2b	18.4x
Fri, 03 Jan 2020	JP¥13.3t	JP¥20.0t	JP¥585.2b	18.6x
Mon, 07 Oct 2019	JP¥13.3t	JP¥19.9t	JP¥555.0b	18.7x
Sun, 30 Jun 2019	JP¥13.0t	JP¥19.8t	JP¥580.2b	19.8x


JP Market	0.71%
Consumer Staples	-2.28%
Food	-2.13%
Packaged Foods and Meats	-2.18%
Agricultural Products	0.45%

Company	Last Price	7D	1Y	Valuation
2267 Yakult HonshaLtd	JP¥6.98k	7.2% +JP¥74.9b	20.6%	PS24.8x
2875 Toyo Suisan Kaisha	JP¥4.57k	4.7% +JP¥20.9b	1.7%	PS20.8x
2222 Kotobuki Spirits	JP¥7.08k	7.3% +JP¥14.9b	7.8%	PS115.1x
2264 Morinaga Milk Industry	JP¥4.75k	4.2% +JP¥8.6b	-20.1%	PS6.3x
2811 Kagome	JP¥3.32k	1.8% +JP¥5.2b	10.5%	PS29.1x

May 18

Morinaga Milk Industry Co., Ltd. Obtains the Registration of New Food Ingredient in China for Use of Probiotic Bifidobacterium Longum BB536 in Infant and Toddler Foods

Morinaga Milk Industry Co., Ltd. announced its proprietary probiotic Bifidobacterium longum BB536 was approved by the National Health Commission (NHC) of the People’s Republic of China as a new food ingredient for use in infant and toddler foods (under the age of three) on 11thMay 2022. Following a complex and lengthy registration process, the probiotic strain B. longum BB536 meets the highest standards of safety and regulatory compliance and has now completed the approval process for use as an ingredient in infant and toddler milk and food products for children under three years old in China. The ‘ New Food Ingredient’ is a regulatory system required for food ingredients to be specifically permitted for use in general foods and infant and toddler foods (<3 years) in China. The registered ingredient must meet certain requirements in terms of nutrition, health, and safety and comply with the regulatory standards in China. To date, there are only 13 registered probiotic strains that can be used in infant and toddler foods in China (six strains in 2011, three in 2016, three in 2020, and one in 2021). The company’s strain, B. longum BB536, is a new addition to the positive list. Morinaga Milk is the only Japanese company to have obtained the registration for probiotic strains. B. longum BB536 is the company’s second strain to have obtained the approval, following B. breve M-16V in 2016. The company focuses on human-residential bifidobacteria (HRB) – the natural inhabitants of the human gut that exhibit numerous superior physiological functions. Morinaga Milk is committed to develop high quality, safe, reliable and natural probiotics over the past decades and is some way ahead of the curve in HRB research. Both BB536 and M-16V approved by the China’s NHC are the HRB strains. The Chinese infant and toddler milk market has tripled in size in the 10 years between 2010 and 2019, and is expected to be worth $24.4 billion in 2020, accounting for 47% of the global market (Euromonitor International ‘ Milk Formula in China’, September 2021). In addition, the market for infant and toddler milk containing the probiotics Bifidobacterium strain has been on the rise in recent years (Research by Morinaga Milk Industry Co., Ltd. using Mintel GNPD, November 2021). Under the Morinaga Milk Group's 10-Year Vision, the company aims to achieve a global business sales ratio of 15% or more by the fiscal year ending March 2029. The company is eyeing the giant infant and toddler milk market in China and aims to strengthen its sales in China to help achieve the goal. Morinaga Milk’s B. longum BB536 has received the FDA GRAS notification in US for use in conventional foods (GRAS Notice No. GRN 000268) and infant and toddler milk (GRAS Notice No. GRN 000877). It has been incorporated in various products worldwide for more than 50 years. Affirmation of this newest registration in China adds value to the company’s proprietary probiotic strain, diversifying its application options available in the infant category.

Japanese (NIKKEI) Packaged Foods and Meats Industry Analysis

Industry Valuation and Performance

Industry Comparison

Top Stock Gainers and Losers

Latest News

2222

Full year 2022 earnings: EPS and revenues exceed analyst expectations

2264

Morinaga Milk Industry Co., Ltd. Obtains the Registration of New Food Ingredient in China for Use of Probiotic Bifidobacterium Longum BB536 in Infant and Toddler Foods

2872

Investor sentiment improved over the past week

2875

Now 20% undervalued after recent price drop

2805

Full year 2022 earnings: EPS and revenues exceed analyst expectations

2267

Full year 2022 earnings: EPS exceeds analyst expectations

2002

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

2897

Full year 2022 earnings: EPS and revenues exceed analyst expectations

2269

Full year 2022 earnings: EPS exceeds analyst expectations

2802

Full year 2022 earnings: EPS exceeds analyst expectations

2871

Nichirei Corporation, Annual General Meeting, Jun 24, 2022

2229

Calbee, Inc. Provides Dividend Guidance for the Year 2023

2212

Now 20% undervalued

2811

First quarter 2022 earnings: EPS exceeds analyst expectations

2801

Full year 2022 earnings: EPS in line with analyst expectations despite revenue beat

2217

No independent directors